CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 163750-164041 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1023","span":{"begin":0,"end":291},"obj":"Sentence"},{"id":"T43398","span":{"begin":0,"end":291},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"NA mutations detected in clinical isolates, which confer resistance to the available neuraminidase inhibitors (NAI), include E119Vand H274Y, which confer resistance to oseltamivir only, and R292K and R152K, which confer resistance to both oseltamivir and zanamivir (Wetherall et al., 2003) ."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T91","span":{"begin":0,"end":291},"obj":"Sentence"}],"text":"NA mutations detected in clinical isolates, which confer resistance to the available neuraminidase inhibitors (NAI), include E119Vand H274Y, which confer resistance to oseltamivir only, and R292K and R152K, which confer resistance to both oseltamivir and zanamivir (Wetherall et al., 2003) ."}